Western blot experiments showed that the Rg3–NIR could reduce the expression of drug resistance‐related proteins BCRP and MDR, indicating that Rg3–NIR could reverse breast cancer drug resistance by reducing the expression of drug resistance‐related proteins. Here, ABCG2 is linked to breast cancer.